Literature DB >> 20872779

Treatment of sleep disturbance in Alzheimer's dementia.

Oludamilola Salami1, Constantine Lyketsos, Vani Rao.   

Abstract

OBJECTIVE: To review the evidence-base behind current treatment options for sleep disturbance in Alzheimer's dementia.
DESIGN: A systematic review synthesized the qualitative and quantitative evidence on the treatment of sleep disturbance in Alzheimer's dementia. Studies with interventions targeting sleep disturbance in Alzheimer's dementia or other aspects of the neuropsychiatric symptoms, but which reported an effect on sleep, were included. The Oxford Center for Evidence-Based Medicine criteria was used in the evaluation and scoring of each study based on the quality of the evidence.
RESULTS: Thirty-eight studies were included. Majority of the studies enrolled participants with mild to moderate Alzheimer's dementia. Outcome measures included objective sleep assessments including polysomnography (PSG) or actigraphy, caregiver reports, sleep logs, and rating scales. The effectiveness of current treatments for sleep disturbance in Alzheimer's dementia is poor. Of the non-pharmacological treatments, bright light therapy (BLT) has the best results. The pharmacological agents produce inconsistent results and their use is further limited by their potential adverse effects.
CONCLUSION: Most current treatments targeting sleep disturbance in Alzheimer's dementia are ineffective. There is a need for further investigation of interventions for treating sleep disturbance in Alzheimer's dementia.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20872779      PMCID: PMC3961760          DOI: 10.1002/gps.2609

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  45 in total

1.  Sleep in dementia.

Authors:  Sonia Ancoli-Israel; Michael V Vitiello
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

2.  A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care.

Authors:  C G Lyketsos; L Lindell Veiel; A Baker; C Steele
Journal:  Int J Geriatr Psychiatry       Date:  1999-07       Impact factor: 3.485

3.  A randomized trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve?

Authors:  C A Alessi; E J Yoon; J F Schnelle; N R Al-Samarrai; P A Cruise
Journal:  J Am Geriatr Soc       Date:  1999-07       Impact factor: 5.562

4.  A multicomponent nonpharmacological intervention improves activity rhythms among nursing home residents with disrupted sleep/wake patterns.

Authors:  Jennifer L Martin; Matthew R Marler; Judith O Harker; Karen R Josephson; Cathy A Alessi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-01       Impact factor: 6.053

5.  Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial.

Authors:  Susan M McCurry; Laura E Gibbons; Rebecca G Logsdon; Michael V Vitiello; Linda Teri
Journal:  J Am Geriatr Soc       Date:  2005-05       Impact factor: 5.562

6.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

7.  Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia.

Authors:  K Mishima; M Okawa; Y Hishikawa; S Hozumi; H Hori; K Takahashi
Journal:  Acta Psychiatr Scand       Date:  1994-01       Impact factor: 6.392

8.  The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study.

Authors:  Walterandré dos Santos Moraes; Dalva Rollemberg Poyares; Christian Guilleminault; Luiz Roberto Ramos; Paulo Henrique Ferreira Bertolucci; Sergio Tufik
Journal:  Sleep       Date:  2006-02       Impact factor: 5.849

9.  Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm disturbances in Alzheimer disease.

Authors:  E J Van Someren; E J Scherder; D F Swaab
Journal:  Alzheimer Dis Assoc Disord       Date:  1998-06       Impact factor: 2.703

10.  Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease.

Authors:  Philip R Gehrman; Donald J Connor; Jennifer L Martin; Tamar Shochat; Jody Corey-Bloom; Sonia Ancoli-Israel
Journal:  Am J Geriatr Psychiatry       Date:  2009-02       Impact factor: 4.105

View more
  9 in total

Review 1.  [Sleep disorders in dementia patients].

Authors:  E Savaskan
Journal:  Z Gerontol Geriatr       Date:  2015-05-09       Impact factor: 1.281

Review 2.  Sleep and Long-Term Care.

Authors:  Lichuan Ye; Kathy C Richards
Journal:  Sleep Med Clin       Date:  2017-11-22

Review 3.  Effects of music interventions on sleep in older adults: A systematic review.

Authors:  Darina V Petrovsky; Pranav Ramesh; Miranda Varrasse McPhillips; Nancy A Hodgson
Journal:  Geriatr Nurs       Date:  2021-06-02       Impact factor: 2.525

Review 4.  Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series.

Authors:  Iosief Abraha; Joseph M Rimland; Fabiana Mirella Trotta; Giuseppina Dell'Aquila; Alfonso Cruz-Jentoft; Mirko Petrovic; Adalsteinn Gudmundsson; Roy Soiza; Denis O'Mahony; Antonio Guaita; Antonio Cherubini
Journal:  BMJ Open       Date:  2017-03-16       Impact factor: 2.692

Review 5.  Sleep and Attention in Alzheimer's Disease.

Authors:  Mirna Hennawy; Solomon Sabovich; Celina S Liu; Nathan Herrmann; Krista L Lanctôt
Journal:  Yale J Biol Med       Date:  2019-03-25

6.  Pilot Study of the Effects of Bright Ambient Therapy on Dementia Symptoms and Cognitive Function.

Authors:  Chuen-Ru Liu; Yiing Mei Liou; Jwo-Huei Jou
Journal:  Front Psychol       Date:  2021-12-24

7.  Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial.

Authors:  W Joseph Herring; Paulette Ceesay; Ellen Snyder; Donald Bliwise; Kerry Budd; Jill Hutzelmann; Joanne Stevens; Christopher Lines; David Michelson
Journal:  Alzheimers Dement       Date:  2020-01-15       Impact factor: 21.566

Review 8.  Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.

Authors:  Jennifer Y Y Szeto; Simon J G Lewis
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

9.  Community Pharmacists' Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with AD.

Authors:  Marketa Marvanova; Paul Jacob Henkel
Journal:  Pharmacy (Basel)       Date:  2017-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.